Pharmaceutical / Drug Definition :
Increases sodium and water excretion by inhibiting sodium reabsorption in distal tubule; enhances excretion of sodium, chloride, potassium, and water. May cause arteriolar vasodilation.
In the United States, Indapamide is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Indapamide.
Registrar Corp assists Indapamide companies with:
FDA Label Requirements and Exceptions
FDA Import Information
Indapamide (Indapamide Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Indapamide (Indapamide Suppliers)
- Processors Indapamide
- Repackers Indapamide
- Relabelers Indapamide
- Exporters Indapamide
- Importers Indapamide
For more information about Indapamide, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.